Position: QC Analyst
Location: Jeddah, Plant
Job Summary:
Responsible for the analysis of all SAJA Stability Studies, Finished Products, and Raw Materials received at the SAJA plant, in compliance with GMP and GLP standards.
Objectives:
- Apply all GMP and GLP regulations consistently.
- Analyze all SAJA Finished Product samples in accordance with the approved QCSM.
- Conduct regular daily and periodic analyses.
- Perform analysis of all raw materials received at SAJA, based on the latest pharmacopeial monographs and GLP guidelines.
- Carry out stability study analyses for all products.
- Prepare comprehensive reports based on analytical results.
- Submit analysis and test reports to the direct manager.
- Accurately record all analytical results in compliance with the QC system.
- Record and monitor the conditions of stability chambers.
- Calibrate balances and pH meters.
- Manage and reserve retained samples.
- Control and monitor the inventory of chemicals and solvents.
- Perform other duties as assigned by the direct supervisor or manager.
Requirement :
- Diploma in Pharmacy
- Bachelor’s degree in Science or Pharmacy
- Minimum of one year in a related field
- Team-oriented with strong collaboration skills
- Ability to work under pressure
- High level of accuracy and attention to detail
- Proficient in Microsoft Office and related computer applications
Languages :-
- Arabic: Mandatory
- English: Important
Skills Required
- Diploma in Pharmacy
- Bachelor's degree in Science or Pharmacy
- Minimum one year of experience in a related field
- Team-oriented with strong collaboration skills
- Ability to work under pressure
- High accuracy and attention to detail
- Proficiency in Microsoft Office and related computer applications
- Arabic language proficiency
- English language proficiency
What We Do
Farouk, Maamoun, Mohammed Said Tamer Industries Ltd. (FMTI) is a Saudi holding and investment company within Tamer Group. Its stated focus is investing in industrial projects related to healthcare and consumer goods. FMTI is also identified as a majority shareholder in Saudi Arabian Japanese Pharmaceutical Co. Ltd., linking it to pharmaceutical manufacturing and the broader healthcare and consumer-products activities of Tamer Group in Saudi Arabia.
